Thoma Bravo
Recent News About Thoma Bravo
-
Rohde: 'It has been a pleasure working with MDP, Flint and the entire Syntellis team to create a truly best-in-class EPM leader'
On Aug. 8, Madison Dearborn Partners (MDP) and Thoma Bravo revealed they successfully finalized the transaction selling Syntellis Performance Solutions, a supplier of enterprise performance management (EPM) software, data and intelligence solutions to Roper Technologies, Inc. (“Roper”) for an all-cash payment amounting to an enterprise value of $1.4 billion. Subsequently, Syntellis will be integrated with Roper’s Strata Decision Technology business, according to a press release.
-
Yules: 'We are excited to work with both of these organizations on the next phase of their growth journey'
Software-investment firm Thoma Bravo announced July 17 that it has finalized a strategic growth investment in Bluesight, the Medication Intelligence™ Company. The investment is set to strengthen Bluesight's drug diversion prevention capabilities, achieved through its acquisition of Medacist.